Article
The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.
Clinical pharmacology and therapeutics - 1 Apr 2016
O'Donnell P H, Danahey K, Ratain M J
Abstract excerpt
The field of pharmacogenomics originally emerged in the 1950s from observations that a few rare individuals had unexpected, severe reactions to drugs. As recently as just 6 years ago, prominent views on the subject had largely remained unchanged, with authors from the US Food and Drug Administration (FDA) citing the purpose of pharmacogenetics as "tailoring treatment for the outliers." It should not be surprising...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.